A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women

Last updated: October 11, 2012
Sponsor: Watson Pharmaceuticals
Overall Status: Completed

Phase

4

Condition

Menopause

Treatment

N/A

Clinical Study ID

NCT00224094
ALO0102
  • Ages 42-70
  • Female
  • Accepts Healthy Volunteers

Study Summary

This study compares the effects of 12 weeks of treatment with transdermal versus oral estrogen therapy on testsoterone levels and thyroid tests in healthy, naturally menopausal women.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Healthy

  • Naturally menopausal women

  • Aged 42-70 years

  • Currently using combination estrogen-progestin replacement therapy

Exclusion

Exclusion Criteria:

  • Women with contraindications to HRT use, including:Unexplained vaginal bleeding, liverdisease, breast or endometrial cancer, venous thromboembolic events

  • Thyroid disease

  • Adrenal disease

Study Design

Total Participants: 27
Study Start date:
January 01, 2002
Estimated Completion Date:

Connect with a study center

  • Massachusetts General Hospital

    Boston, Massachusetts 02114
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.